Efficacy and safety of nanosomal docetaxel lipid suspension-based chemotherapy in squamous cell carcinoma of the head and neck: A multicenter retrospective study.

Kumar Das Majumdar, Saroj; Subramanian, Sundaram; Biswas, Ghanashyam; Joshi, Nisarg; Khan, Mujtaba A; Ahmad, Imran

Kumar Das Majumdar, Saroj; Subramanian, Sundaram; Biswas, Ghanashyam; Joshi, Nisarg; Khan, Mujtaba A; Ahmad, Imran.

Afiliación

Kumar Das Majumdar S; Department of Radiotherapy, All India Institute of Medical Sciences, Bhubaneswar, Odisha 751019, India.
Subramanian S; Department of Medical Oncology, VS Hospital, Madras Cancer Institute, Advanced Cancer Care, Chennai, Tamil Nadu 600031, India.
Biswas G; Department of Medical Oncology, Sparsh Hospital, Bhubaneswar, Odisha 751007, India.
Joshi N; Department of Medical Affairs and Clinical Development, Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat 380054, India.
Khan MA; Department of Medical Affairs and Clinical Development, Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat 380054, India.
Ahmad I; Jina Pharmaceuticals Inc., Libertyville, IL 60048, USA.

Oncol Lett ; 20(6): 344, 2020 Dec.

Article en En | MEDLINE | ID: mdl-33123255

Palabras clave

DoceAqualip; nanosomal docetaxel lipid suspension; squamous cell carcinoma of the head and neck

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Oncol Lett Año: 2020 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google